Renal Cell Cancer Update

PARP Inhibitors in Ovarian Cancer with Dr Antonio González-Martín

Informações:

Sinopse

Dr Antonio González-Martín from the Clínica Universidad de Navarra in Madrid discusses the latest clinical data on and optimal integration of PARP inhibitors in ovarian cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayFrontLineCLL21).